Exploring Best Practices and Innovation in New Registry Handbook: Part 2 - Understanding Quality
Date:
August 6, 2020
Related Content
September 29, 2026
The Fit-for-Purpose Gap: What RWD Still Gets Wrong
Sponsor:
Norstella
Adigens Health
September 1, 2026
Getting COA strategy right from the start: Early endpoint decisions that strengthen evidence and reduce risk
Sponsor:
ICON
July 30, 2026
Filling the Gap: Integrating Patient-Generated Data into Real-World Evidence
Sponsor:
Veradigm
July 14, 2026
Integrated Evidence Generation Planning: Driving Successful Reimbursement and Life Cycle Management
Sponsor:
OPEN Health
July 14, 2026
Navigating the Clinical Outcomes Maze: An Overview of Clinical Outcomes Assessments and Why Training Matters
Sponsor:
ICON
July 14, 2026
Cutting Edge Conversations: Value, Access and Evidence - Biotech Market Access
Sponsor:
PRECISIONheor
OPEN Health
PRMA Consulting
July 13, 2026
Closing Gaps in Care: Health Equity and the Inflation Reduction Act - A Cutting Edge Conversation
Sponsor:
The PPD clinical research business of Thermo Fisher Scientific Inc.
Panalgo, LLC
July 13, 2026
Addressing Orphan and Rare Diseases - A Cutting Edge Conversation
Sponsor:
HealthLumen
ICON
July 13, 2026
"S" Stands for Systematic: Demystifying the Systematic Literature Review
Sponsor:
ICON
June 15, 2026
Network meta-analysis and its role in evidence-based decision-making
Sponsor:
ICON
June 15, 2026
Joint Clinical Assessment 2025: Pioneering Pathways for Oncology, Advanced Therapies & Rare Diseases
Sponsor:
ICON
June 15, 2026
RWE reality check: Routine patient health records and regulatory requirements
Sponsor:
Cardinal Health
June 15, 2026
Survival Analysis for Immature Data: A Review of Techniques and Lessons Learned
Sponsor:
ICON
June 15, 2026
Strategies to Optimize Commercialization of Oncology Treatments for Younger Adults
Sponsor:
ICON
June 15, 2026
EU HTA Joint Clinical Assessments: Navigating Potential Challenges Ahead of 2025
Sponsor:
OPEN Health
June 15, 2026
What Every Researcher Needs to Know About Using Medicare Data for Real World Evidence
Sponsor:
PHAR
June 15, 2026
Streamlining Health Technology Assessments by Automating Literature Reviews
Sponsor:
DistillerSR
June 15, 2026
Optimize Your Value Story Through Integrated Evidence Generation - From Bench to Patient
Sponsor:
Syneos Health
June 15, 2026
Understanding Health Care Decision Maker Preferences for Optimized Engagement
Sponsor:
ICON
June 15, 2026
How Cerner Enviza Uses Clinical Data to Drive RWE Decisions
Sponsor:
Cerner Enviza
June 15, 2026
Optimizing Real-World Evidence for Maternal and Neonatal Outcomes
Sponsor:
HealthCore, Inc.
June 15, 2026
How Literature Review Automation and Efficient Processes Streamline RWE HEOR Studies
Sponsor:
DistillerSR
June 12, 2026
The Scientific and Operational Elegance of Study Replication with Real-World EHR Data: A Vitiligo and Alopecia Example
Sponsor:
Panalgo, LLC
June 12, 2026
Patient Voices Matter: Transforming Industry-Sponsored Real-World Evidence with Patient-Centric Approaches
Sponsor:
Carelon Research
June 12, 2026
Bridging the Gap: Strategies for Patient-Centered Real-World Evidence in Rare Diseases
Sponsor:
Inspire
June 12, 2026
Partnering with Disease Registries: The Value and Impact for Real-World Evidence Generation
Sponsor:
Evidera, part of PPD
June 12, 2026
Minimizing the Impact of Cross-Cultural Differences in COA Translations
Sponsor:
ICON
June 12, 2026
Finding Value in Linking Real-World Data with Social Determinants of Health
Sponsor:
Magnolia Market Access
June 12, 2026
Accelerating the Generation of Payer Insights and Evidence Across the Product Lifecycle to Achieve Optimal Access
Sponsor:
Genesis Research Group
June 7, 2026
Advancing identity data management for digital engagement: How leading organizations are doing it
June 7, 2026
Keeping up with demands for healthcare outside of the hospital: Critical ways tech supports the distributed care model
June 7, 2026
Driving value from healthcare data: How integrated cloud-based data is foundational to drive enterprise change
June 7, 2026
Connected communities: Advancing population health through data and emerging technology
June 7, 2026
From Challenges to Opportunities: Navigating the EU MDR as a Medical Device Manufacturer
June 7, 2026
HTA Implementation in the MEA Region - an Overview from WHO and Country Updates
June 7, 2026
Improving Treatment Access & Outcomes by Integrating Social Determinants of Health Data with Real-World Evidence
June 7, 2026
Webcast: Taking the Complexity Out of Leveraging Health Plan Price Transparency Data
June 7, 2026
Beyond the payment variance report: How to resolve common, costly underpayment issues
June 7, 2026
Looking Beyond Survival Data: Understanding the Value of Non-OS Endpoints in Oncology Reimbursement Decision-Making
June 7, 2026
Measuring the intangible- what is the true value of a "patient centric" initiative
June 7, 2026
The Biotech landscape: Market trends, priorities, predictions, and pathways to FDA approval
June 7, 2026
Fit for Local Context? Establishing or Improving Deliberative Processes for HTA
June 7, 2026
US Drug Pricing Reform: Potential impact on Pharma HEOR Evidence Generation - September 8th
June 7, 2026
Biology's modern LIMS for labs of the future - August 17 | 12:00 pm - 1:00 pm EDT
June 7, 2026
AI and Machine Learning Technologies: The New Normal of the Pharmaceutical Industry - July 27th
June 7, 2026
Digital Transformation to Support Operational, Therapeutic and Clinical Decision Making
June 7, 2026
It's Not FAIR! Improving Data Publishing Practices in Research-Interoperability
June 7, 2026
Exploring Best Practices and Innovation in New Registry Handbook: Part 2 - Understanding Quality
June 7, 2026
Rise of the Robots 2.0: Real Talk About Artificial Intelligence In Systematic Reviews
June 7, 2026
Informational Webinar & Alumni Panel: Online MS Degree, Pharm Outcomes & Policy
June 7, 2026
Patient-Centric RWE Research & Remote Monitored Care: Learnings from a support program leveraging telehealth & connected devices
June 7, 2026
Health Economic and Outcome Research (HEOR) for Medical Technologies for the US Healthcare Systems
Sponsor:
Alira Health
June 7, 2026
Evidence Synthesis for Sparse Evidence Base, Heterogeneous Studies, and Disconnected Networks
Sponsor:
ICON
June 7, 2026
Using External Control Arm Studies in HTA Submissions: An Alternative, When RCTs are not Feasible
Sponsor:
ICON
June 7, 2026
Can Literature Review Automation Improve Healthcare Cost-Effectiveness Analysis and Budget Impact Modeling Outcomes?
Sponsor:
PHAR
June 7, 2026
Value-Based Agreements - Are We Going to See More or Less of Them?
Sponsor:
Actu-Real
June 7, 2026
Respiration in Anesthetized Mice: Evidence-Based Recommendations for Improved Monitoring & Supportive Care
Sponsor:
Kent Scientific Corporation
Related Content
See it in Action
The Digital Backbone for Modern Life Sciences
Discover how one intelligent platform helps teams connect providers, workflows, approvals, compliance, data, and spend—so complex projects move faster with greater visibility and control.